BALL GROUND, Ga. (June 3, 2020)—CAIRE Inc., a provider of respiratory solutions for the global health care community, announced the acquisition of Spirosure, Inc. Spirosure is a California-based developer and manufacturer of a technology for measuring Fractional Exhaled Nitric Oxide (FeNO), a key indicator of allergic inflammation in asthmatic patients.
CAIRE Inc.
BALL GROUND, Ga. (August 31, 2018)—CAIRE Inc. has announced the launch of a new global campaign, oneCAIRE, designed to recognize the unique individual needs of each business partner, and ensure both the company and their partners succeed.
BALL GROUND, Ga. (March 26, 2018)—CAIRE Inc. was accredited by Accreditation Commission for Health Care (ACHC) for the services of delivering health care oxygen therapy products and services to consumers.
The website connects with oxygen users to offer peace of mind.
BALL GROUND, Ga. (September 21, 2017)—CAIRE Inc. rolled out new branding and content on its website, cairemedical.com, this month.
BALL GROUND, Ga. (August 30, 2016)—CAIRE Inc., a Chart Industries Company, announced the implementation of a Minimum Advertised Price Policy (MAP Policy) applicable to all distributors, retailers and resellers who advertise or sell CAIRE products over the Internet. CAIRE’s MAP Policy is effective as of September 1.
BALL GROUND, Ga. (October 20, 2015)—CAIRE Inc., a globally recognized brand in oxygen therapy announces early sign-up for its FreshAire customer portal will take place on the tradeshow floor of the 2015 Medtrade Fall Conference. Logging in to the portal will allow providers access to clinical data, education and VIP services and events. Customers can choose to participate in a frequent buyer program and take advantage of monthly specials.